Global Markets for Bioseparations for Biopharmaceutical Manufacturing to Jump to $6 Billion by 2018

Wednesday 20 November 2013, Amsterdam

This new report, “Global Markets for Bioseparations for Biopharmaceutical Manufacturing,” cites that the global market for bioseparations for biopharmaceutical manufacturing will grow to $6 billion by 2018. While North America and Europe will continue to account for a significant share of revenue, the emerging countries of China, India, Brazil and Russia are rapidly increasing share, growing at a CAGR of 22%.

The demand for single use products is increasing and fueling growth of the global bioseparations market. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. The Asian countries of India, Singapore, South Korea and China are fast becoming biomanufacturing hubs, producing biosimilars for their own large populations and for Southeast Asia.

Bioseparations systems can be categorized into three types: chromatography, membranes/filters and centrifuges. In this report, each is examined in detail, including market size, drivers and restrictors, competitors and technology. In 2013, chromatography will contribute $1.8 billion to the global bioseparations market. Membranes/filters will contribute $1.4 billion, followed by centrifuges ($400 million).

The “Global Markets for Bioseparations for Biopharmaceutical Manufacturing” report covers:

•    Single use products
•    Manufacturing capacity
•    Applications of bioseparations in downstream processing
•    Downstream processing bottlenecks
•    Emerging bioseparations technologies
•    Manufacturing capacity by biopharmaceutical company, CMO and region
    
The “Global Markets for Bioseparations for Biopharmaceutical Manufacturing” report examines companies manufacturing biopharmaceutical manufacturing equipment and supplies in the world. Companies covered include: Alfa Laval, Alfa Wasserman, Applied Biosystems (Life Technologies), Asahi Kasei, BAC B.V. (Life Technologies), Bio-Rad, Carr Centritech, Celeros, Dow Chemical Company, DSM Biologics, Flottweg, G-Con, GEA Westfalia, GE Healthcare Life Sciences, Hitachi Koki, Knauer, Kronlab Division YMC Europe, 3M Purification (CUNO), Merck Millipore, Novavax, Novasep, NuSep, Pall Corporation, PriME, ProMetric, Sartorius, SciLog, Spectrum, Tarpon, Tosoh and Waters.